DPYSL2 maps to 8p21 and encodes a highly conserved phosphoprotein, CRMP2, which plays key roles in the specification and growth of axons. CRMP2 is a member of the DISC1 interactome and also binds microtubules and functions as a cargo receptor to traffic certain essential proteins (e.g. tubulin heterodimers, the SRA1-WAVE1 complex and others) towards the growing end of the developing axon. CRMP2 function has also shown to be involved in the endocytosis of neural adhesion molecules in the axon growth cone and semaphorin 3A mediated growth cone collapse. Evidence from several sources including genomewide linkage and association scans, candidate gene association studies and from our preliminary studies on the functional consequences of sequence variants all implicate certain DPYSL2 variants as conferring risk for schizophrenia (SZ). Also, our preliminary data indicate that certain of the variants confer a sex-specific risk for SZ and relate expression of DPYSL2 variants to mTOR signaling and environmental variables. Thus, these rare genetic variants suggest a mechanism for relating environmental factors such as perinatal stress to risk for SZ. In this proposal we will perform additional large scale sequencing studies to develop an exhaustive catalog of DPYSL2 variants and we will then determine the functional consequences of these perturbations in DPYSL2/CRMP2 function. To accomplish the latter, we will produce and characterize a conditional mouse model for loss of DPYSL2 function. We will also develop cellular and zebrafish systems to test the functional consequences of DPYSL2 variants. Finally, we will explore the role of mTOR signaling in regulating the expression of DPYSL2 at the level of translation and how this is perturbed by certain DPYSL2 variants. As we identify and understand functional variants in DPYSL2, we will also relate this information to the extensive catalog of phenotypic differences of our rigorously characterized SZ patient sample.

Public Health Relevance

Strong genetic and biologic evidence implicates variants in the DPYSL2 gene as conferring risk for SZ. We intend to expand the list of risk alleles and understand the mechanisms by which these genetic variants increase risk for SZ. Our preliminary results suggest that the risk conferred by variation in DPYSL2 function depends on the sex of the subject and interacts with environmental variables known to be associated with increased risk for SZ.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH094268-04
Application #
8681534
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Prandovszky, Emese; Li, Ye; Sabunciyan, Sarven et al. (2018) Toxoplasma gondii-Induced Long-Term Changes in the Upper Intestinal Microflora during the Chronic Stage of Infection. Scientifica (Cairo) 2018:2308619
Sumitomo, Akiko; Saka, Ayumi; Ueta, Keisho et al. (2018) Methylphenidate and Guanfacine Ameliorate ADHD-Like Phenotypes in Fez1-Deficient Mice. Mol Neuropsychiatry 3:223-233
Weber, Natalya S; Gressitt, Kristin L; Cowan, David N et al. (2018) Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP). Schizophr Res :
Torniainen-Holm, Minna; Suvisaari, Jaana; Lindgren, Maija et al. (2018) Association of cytomegalovirus and Epstein-Barr virus with cognitive functioning and risk of dementia in the general population: 11-year follow-up study. Brain Behav Immun 69:480-485
Li, Ye; Viscidi, Raphael P; Kannan, Geetha et al. (2018) Chronic Toxoplasma gondii Infection Induces Anti-N-Methyl-d-Aspartate Receptor Autoantibodies and Associated Behavioral Changes and Neuropathology. Infect Immun 86:
Lindgren, Maija; Torniainen-Holm, Minna; Härkänen, Tommi et al. (2018) The association between toxoplasma and the psychosis continuum in a general population setting. Schizophr Res 193:329-335
Sedlak, Thomas W; Nucifora, Leslie G; Koga, Minori et al. (2018) Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study. Mol Neuropsychiatry 3:214-222
McFarland, Ross; Wang, Zi Teng; Jouroukhin, Yan et al. (2018) AAH2 gene is not required for dopamine-dependent neurochemical and behavioral abnormalities produced by Toxoplasma infection in mouse. Behav Brain Res 347:193-200
Severance, Emily G; Yolken, Robert H (2018) Deciphering microbiome and neuroactive immune gene interactions in schizophrenia. Neurobiol Dis :
Sumitomo, Akiko; Yukitake, Hiroshi; Hirai, Kazuko et al. (2018) Ulk2 controls cortical excitatory-inhibitory balance via autophagic regulation of p62 and GABAA receptor trafficking in pyramidal neurons. Hum Mol Genet 27:3165-3176

Showing the most recent 10 out of 190 publications